ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine

by Thomas R. Collins • January 15, 2021

  • Tweet
  • Email
Print-Friendly Version

Ashley Wenaas, MDPeople would say, ‘I’m going to get the vaccine, but I’m not going to be the first one. I’ll be in the second wave. I don’t want to be the guinea pig.’ —Ashley Wenaas, MD

You Might Also Like

No related posts.

Explore This Issue
January 2021

Pfizer and BioNTech’s vaccine was found to be safe and 95% effective at preventing infection, and particularly at preventing severe cases. Moderna’s vaccine has also been found to be safe, with a 94.5% efficacy in preventing infection, and, like Pfizer’s, highly effective at preventing severe COVID-19 cases.

A vector vaccine being developed by AstraZeneca contains a weakened version of the live virus that carries genetic material from SARS-CoV-2 into cells. That genetic material prompts production of the spike protein, instigating an immune response. Johnson & Johnson has also developed a vector vaccine, which, as of December 2020, was being assessed in a trial. Sanofi and Novavax are running separate trials to test the efficacy and safety of a protein subunit COVID-19 vaccine.

Even as Operation Warp Speed fed billions of dollars to pharmaceutical companies to manufacture the vaccines, those vaccines were still being studied to see whether they would be safe and effective. Infectious disease experts said the accelerated timeline has been the product of urgency, funding, and raw will—but not through an abandonment of the scientific process.

“Necessity is the mother of invention, and there’s a huge need here,” said Kenneth Alexander, MD, PhD, chief of infectious diseases at Nemours Children’s Health System. “Although this is being done on an accelerated schedule, the researchers aren’t taking shortcuts.” In addition, the sheer number of people in the studies—tens of thousands—should be reassuring. “If you examine the mathematics, an undetectable side effect would have to happen in the neighborhood of 1 in 10,000 people or fewer,” he said.

Despite this rigorous process, the U.S. population is split in its views of COVID-19 vaccines. Survey data released from the Pew Research Center in September 2020 showed that 51% of U.S. adults said they would definitely or probably get a vaccine, while 49% said they would definitely or probably not get one.

Those percentages have been fluid: Earlier, in May 2020, 72% said they would be at least likely to receive a vaccine. But after the September drop, more recent poll results, released in December 2020 by the Kaiser Family Foundation, found that 71% of respondents would definitely or probably get a vaccine.

Dr. Hotez believes the number of people who would get a vaccine will increase as the rollout continues. “I think a large part of that [hesitation] could evaporate as people start to get vaccinated and see no untoward effects,” he said. “I think there’s a group that is concerned about all the politicization they’ve seen in regard to the COVID-19 vaccines. With adequate communication, that part can be fixed.”

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Home Slider Tagged With: COVID19, patient care, vaccinesIssue: January 2021

You Might Also Like:

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Some Studies Predict a Shortage of Otolaryngologists. Do the Numbers Support Them?
    • Neurogenic Cough Is Often a Diagnosis of Exclusion
    • Complications for When Physicians Change a Maiden Name
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • Tympanoplasty Tips: Otology Experts Give Advice on the Procedure
    • How Treatment for Obstructive Sleep Apnea (OSA) Is Evolving to Give Patients a Better Night’s Sleep
    • Vestibular Schwannoma Position Relative to Internal Auditory Canal Helps Predict Postoperative Facial Function
    • Vocal Fold Lipoaugmentation Provides Long-Term Voice Improvements for Glottal Insufficiency
    • Upper Lateral Cartilage Mucosal Flap Enables the Successful Closure of Larger Septal Perforations

Polls

Do you think there will be a shortage of otolaryngologists in the next five to 10 years?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2022 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.